BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cormier JN, Vauthey JN. Biliary tract cancer. Curr Opin Gastroenterol 2000;16:437-43. [PMID: 17031117 DOI: 10.1097/00001574-200009000-00009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
Number Citing Articles
1 Zimmermann A. Hilar/Perihilar Cholangiocarcinoma (Klatskin Tumor). Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2017. [DOI: 10.1007/978-3-319-26956-6_27] [Reference Citation Analysis]
2 Zimmermann A. Hilar/Perihilar Cholangiocarcinoma (Klatskin Tumor). Tumors and Tumor-Like Lesions of the Hepatobiliary Tract 2016. [DOI: 10.1007/978-3-319-26587-2_27-1] [Reference Citation Analysis]
3 Nanashima A, Sumida Y, Tobinaga S, Abo T, Takeshita H, Sawai T, Hidaka S, Fukuoka H, Nagayasu T. Characteristics of bile duct carcinoma with superficial extension in the epithelium. World J Surg 2009;33:1255-8. [PMID: 19363579 DOI: 10.1007/s00268-009-9993-6] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Guglielmi A, Ruzzenente A, Iacono C. Prognostic Factors. Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma 2008. [DOI: 10.1007/978-88-470-0729-1_8] [Reference Citation Analysis]
5 Chen RF, Li ZH, Zhou JJ, Wang J, Chen JS, Lin Q, Tang QB, Peng NF, Jiang ZP, Zhou QB. Preoperative evaluation with T-staging system for hilar cholangiocarcinoma. World J Gastroenterol 2007; 13(43): 5754-5759 [PMID: 17963304 DOI: 10.3748/wjg.v13.i43.5754] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
6 Merchant JL. Tales from the crypts: regulatory peptides and cytokines in gastrointestinal homeostasis and disease. J Clin Invest 2007;117:6-12. [PMID: 17200701 DOI: 10.1172/JCI30974] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]